B cells

Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjögren's syndrome
R P E Pollard, W H Abdulahad, H Bootsma, P M Meiners, F K L Spijkervet, M G Huitema, J G M Burgerhof, A Vissink, F G M Kroese

Annals of the Rheumatic Diseases Dec 2013, 72 (12) 2048-2050; DOI: 10.1136/annrheumdis-2013-203447
Fetal outcomes after rituximab exposure in women with autoimmune vasculitis
William F Pendergraft, Martina M McGrath, Andrew P Murphy, Patrick Murphy, Karen A Laliberte, Michael F Greene, John L Niles

Annals of the Rheumatic Diseases Dec 2013, 72 (12) 2051-2053; DOI: 10.1136/annrheumdis-2013-203833
B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis
Andrea Cortini, Ursula Ellinghaus, Talat H Malik, Deborah S Cunninghame Graham, Marina Botto, Timothy James Vyse

Annals of the Rheumatic Diseases Dec 2017, 76 (12) 2095-2103; DOI: 10.1136/annrheumdis-2017-211499
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis
Josef S Smolen, Stanley B Cohen, Hans-Peter Tony, Morton Scheinberg, Alan Kivitz, Andra Balanescu, Juan Gomez-Reino, Liyi Cen, Peijuan Zhu, Tamas Shisha

Annals of the Rheumatic Diseases Sep 2017, 76 (9) 1598-1602; DOI: 10.1136/annrheumdis-2017-211281
Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis
Priscilla F Kerkman, Emeline Fabre, Ellen I H van der Voort, Arnaud Zaldumbide, Yoann Rombouts, Theo Rispens, Gertjan Wolbink, Rob C Hoeben, Hergen Spits, Dominique L P Baeten, Tom W J Huizinga, René E M Toes, Hans U Scherer

Annals of the Rheumatic Diseases Jun 2016, 75 (6) 1170-1176; DOI: 10.1136/annrheumdis-2014-207182
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
Konstantina Delli, Erlin A Haacke, Frans G M Kroese, Rodney P Pollard, Stephan Ihrler, Bert van der Vegt, Arjan Vissink, Hendrika Bootsma, Frederik K L Spijkervet

Annals of the Rheumatic Diseases Nov 2016, 75 (11) 1933-1938; DOI: 10.1136/annrheumdis-2015-208304
Towards standardisation of histopathological assessments of germinal centres and lymphoid structures in primary Sjögren's syndrome
Maarten R Hillen, Francesca Barone, Timothy RDJ Radstake, Joel AG van Roon

Annals of the Rheumatic Diseases Jun 2016, 75 (6) e31; DOI: 10.1136/annrheumdis-2016-209475
Do high numbers of salivary gland-infiltrating B cells predict better or worse outcomes after rituximab in patients with primary Sjögren's syndrome?
Divi Cornec, Sebastian Costa, Valérie Devauchelle-Pensec, Laurent Chiche, Alain Saraux, Jacques-Olivier Pers

Annals of the Rheumatic Diseases Jun 2016, 75 (6) e33; DOI: 10.1136/annrheumdis-2016-209300
In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI
Konstantina Delli, Erlin A Haacke, Frans GM Kroese, Rodney P Pollard, Stephan Ihrler, Bert van der Vegt, Arjan Vissink, Hendrika Bootsma, Frederik KL Spijkervet

Annals of the Rheumatic Diseases Jun 2016, 75 (6) e34; DOI: 10.1136/annrheumdis-2016-209317
Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus
Sarah A Jones, Andrew E J Toh, Dragana Odobasic, Marie-Anne Virginie Oudin, Qiang Cheng, Jacinta P W Lee, Stefan J White, Brendan E Russ, Simona Infantino, Amanda Light, David M Tarlinton, James Harris, Eric F Morand

Annals of the Rheumatic Diseases Apr 2016, 75 (4) 739-747; DOI: 10.1136/annrheumdis-2015-207744

Main menu

B cells

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

B cells

Pages